When There’s No Appointment Available, Patients Are Opening ChatGPT
The limitations of general-purpose AI in an emotional support context aren't what it says. They're about what it can't detect, including the markers of acute distress that a purpose-built system is specifically architected to recognize.
How States Can Succeed Under the Rural Health Transformation Program
Is $50 billion over five years enough to end the rural healthcare crisis or even offset the federal spending cuts? No – but it’s what states have to work with. And the pressure is on them to maximize the impact of their RHTP grants. Here’s how they can do it.
Healthcare Bankruptcies Rise in Q1: 6 Things to Know
A new report from Gibbins Advisors showed that healthcare bankruptcy filings rose 33% in the first quarter of 2026, driven mostly by outpatient and senior care providers. At the same time, hospital M&A activity rebounded to its strongest first quarter since early 2020.
Angelini Pharma’s $4B Acquisition Adds Rare Disease Drugs to a Global Growth Strategy
Angelini Pharma’s acquisition of Catalyst Pharmaceuticals is part of a transformation strategy focused on neurological medicines. Catalyst’s top product is Firdapse, the first FDA-approved drug for a particular rare neuromuscular disorder.
Debunked Episode 26: A Conversation on How to Improve Healthcare
Improving healthcare was a central theme of the latest episode of the Debunked Podcast. The discussion offered perspectives from Louisiana Republican Senator Bill Cassidy, HHS Secretary Robert Kennedy Jr., Devoted Health CEO Ed Park, and Dr. Ezekiel Emanuel, an oncologist and professor with University of Pennsylvania, and Debunked co-hosts Arundhati Parmar and Samir Batra.